Completed
Viral Activation Transfusion Study (VATS)
Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2016-07-12
N/A
Participants Needed
N/A
Research Sites
330 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of the trial was to determine if transfusion of allogeneic blood to HIV-1 infected persons led to immune activation and consequent induction of HIV-1 or /or Cytomegalovirus (CMV) replication, and whether this adversely affected clinical prognosis.
CONDITIONS
Official Title
Viral Activation Transfusion Study (VATS)
Who Can Participate
Eligibility Criteria
You may qualify if you...
HIV-infected patients with CD4 counts below 250 who clinically needed red blood cell transfusions.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Trial Site Locations
Site Locations not provided
Location information for this trial is currently unavailable.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
N/A
Allocation
RANDOMIZED
Model
N/A
Primary Purpose
PREVENTION
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here